Treating Heart Failure With Preserved Ejection Fraction: Learning From Pulmonary Fibrosis

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diffuse Right Ventricular Fibrosis in Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure With Preserved Ejection Fraction

PLoS ONE
Multidisciplinary
2013English

Biomarkers, Myocardial Fibrosis and Co-Morbidities in Heart Failure With Preserved Ejection Fraction: An Overview

Archives of Medical Science
Medicine
2018English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Pulmonary Hypertension in Heart Failure Preserved Ejection Fraction: Prevalence, Pathophysiology, and Clinical Perspectives

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy